World's Best Scientists 2026 revealed!
Philippe Rougier

Philippe Rougier

D-Index & Metrics

Medicine

D-Index
118
Citations
77869
World Ranking
3974
National Ranking
115

Overview

Philippe Rougier is affiliated with the University of Nantes in France, focusing their research primarily within the fields of Medicine and Economics, Econometrics and Finance. Their academic work intersects multiple subfields including Oncology, Surgery, Economics and Econometrics, and Pathology and Forensic Medicine.

Their research addresses various topics, notably:

  • Colorectal Cancer Treatments and Studies
  • Colorectal and Anal Carcinomas
  • Genetic factors in colorectal cancer
  • Economic and Financial Impacts of Cancer
  • Health Systems, Economic Evaluations, Quality of Life

Rougier has contributed to studies published primarily in the venue UNC Libraries, where two of their recorded papers appeared. These publications are:

  • Documenting the Natural History of Patients With Resected Stage II Adenocarcinoma of the Colon After Random Assignment to Adjuvant Treatment With Edrecolomab or Observation: Results From CALGB 9581 (2020, UNC Libraries)
  • Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With Metastatic Colorectal Cancer (2020, UNC Libraries)

Their frequent co-authors include:

  • Richard M. Goldberg
  • Donna Niedzwiecki
  • Monica M. Bertagnolli
  • Robert S. Warren
  • Carolyn C. Compton

Best Publications

  • Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.

    Eric Van Cutsem;Claus Henning Köhne;Erika Hitre;Jerzy Zaluski

  • Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

    J Y Douillard;D Cunningham;Arnaud Roth;M Navarro

  • KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer

    Astrid Lièvre;Jean-Baptiste Bachet;Delphine Le Corre;Valérie Boige

  • Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

    Hansjochen Wilke;Kei Muro;Eric Van Cutsem;Sang Cheul Oh

  • Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Bengt Glimelius;Graeme J Poston

  • Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

    Marc Ychou;Valérie Boige;Jean-Pierre Pignon;Thierry Conroy

  • KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

    Astrid Lièvre;Jean-Baptiste Bachet;Valérie Boige;Anne Cayre

  • Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

    Wendy De Roock;Bart Claes;David Bernasconi;Jef De Schutter

  • Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status

    Eric Van Cutsem;Claus Henning Köhne;István Láng;Gunnar Folprecht

  • Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

    H Bartelink;F Roelofsen;F Eschwege;P Rougier

  • Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer.

    P Piedbois;P Rougier;M Buyse

  • Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983) : long-term results of a randomised, controlled, phase 3 trial

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Graeme J Poston

  • Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study

    Eric Van Cutsem;Chris Twelves;Jim Cassidy;David Allman

  • Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer

    Philippe Rougier;Eric Van Cutsem;Emilio Bajetta;Norbert Niederle

  • A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma.

    P. Rougier;A. Adenis;M. Ducreux;M. de Forni

  • Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis

    Gastric (Global Advanced);Xavier Paoletti;Koji Oba

  • Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and RAS Mutations in Colorectal Cancer

    Eric Van Cutsem;Heinz Josef Lenz;Claus Henning Köhne;Volker Heinemann

  • Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study

    B. Chauffert;F. Mornex;Franck Bonnetain;P. Rougier

  • Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases.

    Mehdi Karoui;Christophe Penna;Mohamed Amin-Hashem;Emmanuel Mitry

  • Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983)

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Graeme J Poston

Frequent Co-Authors

Michel Ducreux
Michel Ducreux Institut Gustave Roussy
Olivier Bouché
Olivier Bouché CHU de Reims
Julien Taieb
Julien Taieb Université Paris Cité
Marc Ychou
Marc Ychou University of Montpellier
Valérie Boige
Valérie Boige Institut Gustave Roussy
Dominique Elias
Dominique Elias Institut Gustave Roussy
Pierre Laurent-Puig
Pierre Laurent-Puig Université Paris Cité
René Adam
René Adam University of Paris-Saclay
Jean-Luc Raoul
Jean-Luc Raoul Institut de Cancérologie de l'Ouest (ICO)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but not sure if a traditional MD is the right fit? There are many alternative online pathways for future healthcare professionals. Nursing is a fast-growing field with plenty of flexible study options. For those seeking advanced education, online nursing doctoral programs provide opportunities for leadership, research, and teaching roles—all from the convenience of home.

For registered nurses aiming to advance their credentials, the cheapest online BSN programs offer affordable pathways to a Bachelor of Science in Nursing, often on a flexible schedule. Those with a non-nursing background can also consider direct entry nurse practitioner programs for non-nurses online, which offer a fast track to becoming a nurse practitioner, even without prior nursing experience.

Wondering where to begin your journey? Some institutions are known for being more accessible. Explore the easiest RN program options to help kick-start your nursing education and get hands-on experience quickly. Exploring these diverse online degrees and career pathways can open doors to meaningful roles across the healthcare sector.

Best Scientists Citing Philippe Rougier

Trending Scientists

Recently Published Articles